Molecular Partners
Molecular Partners AG, a clinical-stage biotechnology company, develops designed ankyrin repeat proteins therapeutics for the treatment of oncology and virology diseases in Switzerland. The company develops MP0317, a CD40 agonist designed to activate immune cells within the tu...
Molecular Partners Logo
About Molecular Partners
Molecular Partners AG develops and markets biopharmaceutical products. The Company develops designed ankyrin repeat protein platform therapies used in ophthalmology, oncology, inflammation, and other therapeutic treatments. Molecular Partners serves healthcare professionals and patients worldwide.
Address
Wagistrasse 14,
Schlieren, 8952
Switzerland
Year founded
1970
Number of employees
100-200
Report inaccurate data
Request an update to help us keep the brand up-to-date.
